There are no factors affecting Combivent® dosage because regardless of age, weight, existing medical conditions or current medications, there is just one standard dosage. The standard Combivent® dosage is two sprays by inhalation, four times per day. Combivent® is used in the treatment of chronic obstructive pulmonary disease (COPD), which includes bronchitis and emphysema. The medication works to keep constricted airways open, facilitating breathing.
Chronic obstructive pulmonary disease can cause excessive sputum production, wheezing, and shortness of breath. In addition, it can cause chest tightness and significant coughing. Although smoking is a major cause of the condition, other causes can contribute to it as well. COPD can generally be well managed, however, the pulmonary damage that it can cause typically cannot be reversed. Quitting smoking can offer an important benefit in the treatment of COPD, preventing further damage to lung tissue.
Other treatments that can be administered in addition to the standard Combivent® dosage are inhaled steroids, the pneumococcal vaccine, bronchodilators, and an annual flu shot. Depending upon the severity of symptoms, the healthcare provider may recommend taking more or less of the standard dosage. It is important for patients to never adjust the Combivent® dosage on their own without first consulting their healthcare providers.
The standard Combivent® dosage can cause side effects such as upper respiratory tract infections, bronchitis, and headaches. In addition, Combivent® can cause chronic coughing, nausea, difficulty breathing, and a sore throat. Sinus infections, flu-like symptoms, and a runny or stuffy nose are also common side effects. When side effects to this medication become severe, the healthcare provider may be able to devise another treatment plan to help relieve symptoms.
Rare and sometimes severe side effects of a standard Combivent® dosage include wheezing, chest pain, and shortness of breath. Other rare but serious effects may include dangerously high or low blood pressure, exacerbation of diabetes, and an irregular heart beat. If any of these symptoms occur, emergency medical intervention can reduce the risk of complications.
The safety of Combinvent® has not been established for use in women who are pregnant or considering becoming pregnant, or for those who are breast feeding. Taking this medication may impair fetal development and may increase blood sugar levels in fetuses. Women who have COPD should discuss alternative treatments with their healthcare providers. Other treatments can help reduce the symptoms of COPD that may pose little threat to the mother or baby.
